webinar register page

Rational Selection and Application of Ready-to-Use Formulations for Self-Emulsifying Drug Delivery Systems
Poorly soluble drugs for oral administration present unique formulation challenges, particularly during early development. Formulation in a lipid-based carrier can be a feasible approach, but usually requires extensive testing to find suitable excipient combination.

To facilitate early formulation development, BASF has developed Ready-to-Use carrier formulations for Self-Emulsifying Drug Delivery Systems (SEDDS). Their characteristics and practical application as well as their rational selection in an interactive web-application are the key topics of this event.

Join this webinar to learn from BASF experts on how the BASF SEDDS Formulary and the Virtual Pharma Assistant ZoomLab™ can support and streamline your formulation challenges

Start: 8:00 AM EST, 2:00 PM CET
(As we get the question from other time zones - there will be a recording of the webinar to view after the Live webinar if you are registered)


* Required information


Lindsay Johnson, PhD
Global Technical Marketing Manager, @BASF Pharma Solutions, Tarrytown, NY
Dr. Johnson, Global Technical Marketing Manager, leads the Solubilization Platform at BASF Pharma Solutions. In her role, Dr. Johnson manages global projects and teams to enable formulations of hydrophobic and highly crystalline active pharmaceutical ingredients through approaches like amorphous solid dispersions, self-emulsifying drug delivery systems, and softgel encapsulation. She also leads the parenterals portfolio for small molecule delivery through injection formulations. Dr. Johnson completed her Ph.D. on pharmaceutical excipients at the University of Minnesota. She has held a range of technical, innovation, and commercial roles within BASF, internationally and domestically.
Martin Hofsaess, PhD
R&D Scientist @BASF Pharma Solutions, Ludwigshafen, Germany
Dr. Martin Hofsaess, Scientist for digital formulation development, is a team member of BASF Development Pharma Solutions located at Ludwigshafen, Germany. In his role, Dr. Hofsaess conceptualizes and develops digital solutions for BASF’s Virtual Formulation Assistant ZoomLab™. The focus of his work is the digitalization of structured development approaches for enabling formulations such as amorphous solid dispersions and lipid-based formulations for solubilizing poorly soluble active pharmaceutical ingredients. Dr. Hofsaess completed his Ph.D. in pharmaceutical technology on the topic in vivo-predictive dissolution testing at the University of Frankfurt, Germany. Before his current position, he held a PostDoc position at BASF Development Pharma Solutions.